![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](ng2704contents.gif)
Acta Cryst. (2010). E66, o163-o164 [ doi:10.1107/S1600536809053410 ]
Abstract: In the title compound, C9H15NO·C6H2Cl2O4 [sytematic name: 2-azaspiro[4.5]decan-3-one-chloranilic acid (1/1)], the cyclohexane ring of the lactam molecule adopts a slightly distorted normal chair conformation and the five-membered 3-azaspiro ring is in a slightly distorted chair conformation. The dihedral angle between the least-squares planes of the cyclohexane and 3-azaspiro rings is 84.0 (3)°. In the crystal, the chloranilic acid molecule and the gabapentin-lactum molecules are held together by strong intermolecular N-H
O and O-H
O hydrogen bonds with two bifurcated O acceptor atoms on the chloranilic acid molecule and one on the gabapentin-lactum molecule, each bonding with an inter- and intramolecular hydrogen bond. The molecules are linked into chains parallel to (011) and propagating along the b axis.
Online 16 December 2009
Copyright © International Union of Crystallography
IUCr Webmaster